<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
<LINK HRef="../css/riziv.css" Rel="stylesheet" Type="text/css">
<META name="description" content="Klasse III">
<META name="keywords" content="analysis chapter II en IV">
<TITLE>SEVIKAR 40 MG/10 MG FILMOMH TABL 98 vw1:  vw2: 5310000</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0" id="bodykw">
 <A Name="TopOfPage"></A>
 <TABLE Width="95%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD Width="70%" vAlign="Top"><H2>SEVIKAR 40 MG/10 MG FILMOMH TABL 98</H2>
   </TD>
   <TD Width="30%" vAlign="Top">
    <H4 Align="right">Source: INAMI Avril 2015</H4>
   </TD>
  </TR>
 </TABLE>


<HR>
 <TABLE width="100%">
  <TR>
   <TD>
<H3 ALign="right"><A Name="#5310000"></A>R&eacute;glementation sur le remboursement selon la cat&eacute;gorie B</H3>
  <H3 ALign="right">Contr&ocirc;le a priori (chapitre IV § 5310000)</H3>

   </TD>
  </TR
 </TABLE>
 <P>
 <TABLE Width="95%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD Width="5%">&nbsp;</TD>
   <TD vAlign="top"><DIV align=center><TABLE style="BORDER-COLLAPSE: collapse; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed" class=MsoNormalTable border=0 cellSpacing=0 cellPadding=0 width=681>    <TR   style="HEIGHT: 72.45pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 510.4pt; PADDING-RIGHT: 5.4pt; HEIGHT: 72.45pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=681>      <P Class="Text">a) La spécialité fait l’objet d’un remboursement en catégorie B       dans le cadre du groupe de remboursement B-306 si elle est utilisée pour       le traitement de patients bénéficiant d’un trajet de soins pour       insuffisance rénale chronique conformément aux dispositions de l’arrêté       royal du 21 janvier 2009 concernant les trajets de soins, et pour autant       que le patient concerné remplisse toutes les conditions médicales       nécessaires pour obtenir le remboursement de la spécialité concernée       telles que ces conditions figurent au paragraphe du chapitre IV de l’A.R.       du 21 décembre 2001 mentionné dans le tableau ci-dessous en regard de la       spécialité concernée&nbsp;:<B       style="mso-bidi-font-weight: normal"></B></P></TD></TR></TABLE></DIV><DIV align=center><TABLE style="BORDER-COLLAPSE: collapse; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed" class=MsoNormalTable border=0 cellSpacing=0 cellPadding=0 width=681>    <TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text">Paragraphe</P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      </TD></TR>  <TR style="mso-yfti-irow: 1">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00262506**qs_SpcNam=1-ALPHA%20LEO**qs_Chp=IV**qs_Prg=190000">190000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">1 ALPHA Leo</P></TD></TR>  <TR style="mso-yfti-irow: 2">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00228352**qs_SpcNam=ROCALTROL**qs_Chp=IV**qs_Prg=200000">200000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">ROCALTROL</P></TD></TR>  <TR style="mso-yfti-irow: 3">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00239466**qs_SpcNam=ENGERIX-B**qs_Chp=IV**qs_Prg=330100">330100</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">ENGERIX B</P></TD></TR>  <TR style="mso-yfti-irow: 4">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">HBVAX PRO</P></TD></TR>  <TR style="mso-yfti-irow: 5">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00436496**qs_SpcNam=RENAGEL**qs_Chp=IV**qs_Prg=2260000">2260000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">RENAGEL</P></TD></TR>  <TR style="mso-yfti-irow: 6">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00477522**qs_SpcNam=COZAAR**qs_Chp=IV**qs_Prg=2430000">2430000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COZAAR</P></TD></TR>  <TR style="mso-yfti-irow: 7">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COZAAR (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 8">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COZAAR PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 9">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COZAAR PLUS FORTE</P></TD></TR>  <TR style="mso-yfti-irow: 10">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COZAAR PLUS FORTE (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 11">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00215622**qs_SpcNam=APROVEL**qs_Chp=IV**qs_Prg=3620000">3620000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">APROVEL</P></TD></TR>  <TR style="mso-yfti-irow: 12">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">ATACAND</P></TD></TR>  <TR style="mso-yfti-irow: 13">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">ATACAND Aktuapharma</P></TD></TR>  <TR style="mso-yfti-irow: 14">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">ATACAND PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 15">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">BELSAR</P></TD></TR>  <TR style="mso-yfti-irow: 16">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">BELSAR PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 17">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">COAPROVEL</P></TD></TR>  <TR style="mso-yfti-irow: 18">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">CO-DIOVANE</P></TD></TR>  <TR style="mso-yfti-irow: 19">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">DIOVANE</P></TD></TR>  <TR style="mso-yfti-irow: 20">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">EXFORGE</P></TD></TR>  <TR style="mso-yfti-irow: 21">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">EXFORGE HCT</P></TD></TR>  <TR style="mso-yfti-irow: 22">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">FORZATEN</P></TD></TR>  <TR style="mso-yfti-irow: 23">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">FORZATEN/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 24">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">KINZALKOMB</P></TD></TR>  <TR style="mso-yfti-irow: 25">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">KINZALMONO</P></TD></TR>  <TR style="mso-yfti-irow: 26">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">MICARDIS</P></TD></TR>  <TR style="mso-yfti-irow: 27">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">MICARDISPLUS</P></TD></TR>  <TR style="mso-yfti-irow: 28">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">MICARDISPLUS (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 29">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">OLMETEC</P></TD></TR>  <TR style="mso-yfti-irow: 30">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">OLMETEC PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 31">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">SEVIKAR</P></TD></TR>  <TR style="mso-yfti-irow: 32">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">SEVIKAR/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 33">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">TEVETEN</P></TD></TR>  <TR style="mso-yfti-irow: 34">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">TEVETEN PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 35">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      </TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">TWYNSTA</P></TD></TR>  <TR style="mso-yfti-irow: 36">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00587252**qs_SpcNam=FENDRIX**qs_Chp=IV**qs_Prg=3740000">3740000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">FENDRIX</P></TD></TR>  <TR style="mso-yfti-irow: 37">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text"><A       href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00611201**qs_SpcNam=FOSRENOL**qs_Chp=IV**qs_Prg=4000000">4000000</A></P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">FOSRENOL</P></TD></TR>  <TR style="mso-yfti-irow: 38">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text">4020100</P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">MIMPARA</P></TD></TR>  <TR style="mso-yfti-irow: 39; mso-yfti-lastrow: yes">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 152.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=203>      <P Class="Text">5560000</P></TD>    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 357.8pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=477>      <P Class="Text">RENVELA</P></TD></TR></TABLE></DIV><DIV align=center><TABLE style="BORDER-COLLAPSE: collapse; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed" class=MsoNormalTable border=0 cellSpacing=0 cellPadding=0 width=681>    <TR   style="HEIGHT: 124.2pt; mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">    <TD     style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 510.4pt; PADDING-RIGHT: 5.4pt; HEIGHT: 124.2pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=681>      <P Class="Text">b) Le remboursement est accordé pour autant que le médecin       prescripteur, constatant que toutes les conditions du paragraphe concerné       au point a) sont remplies pour la spécialité prescrite, y compris les       éventuelles conditions relatives à une posologie maximale remboursable, et       qu’il s’agit d’un patient bénéficiant d’un trajet de soins pour       insuffisance rénale chronique au moment de la prescription, mentionne sur       l’ordonnance «TSI » ou «&nbsp;       trajet de soins insuffisance rénale chronique ». Dans ces       conditions, le pharmacien est habilité à appliquer le tiers payant dans le       cadre du groupe de remboursement B-306.</P>      <P Class="Text">c) Le médecin prescripteur doit tenir à la disposition du       médecin-conseil les éléments de preuve établissant que le patient se       trouve dans la situation susvisée, y compris, le cas échéant, lorsque les       dispositions du paragraphe visé au point a) prévoient que la demande doit       être rédigée par un médecin titulaire d’une qualification médicale       particulière, une attestation d’un médecin possédant cette qualification       qui confirme que les conditions médicales de ce paragraphe sont bien       remplies chez le patient concerné.</P></TD></TR></TABLE></DIV></TD></TR>
 </TABLE>

<HR>
<H3 ALign="right"><A Name="#5510000"></A>R&eacute;glementation sur le remboursement selon la cat&eacute;gorie B</H3>
  <H3 ALign="right">Contr&ocirc;le a priori (chapitre IV § 5510000)</H3>

 <P>
 <TABLE Width="95%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD Width="5%">&nbsp;</TD>
   <TD vAlign="top"><P Class="Text">a) La spécialité fait l’objet d’un remboursement en catégorie B dans le cadre du groupe de remboursement&nbsp; B-310 si elle est utilisée pour le traitement des patients repris dans une convention diabète, pour autant que le patient concerné remplisse toutes les conditions médicales nécessaires pour obtenir le remboursement de la spécialité concernée telles que ces conditions figurent au paragraphe du chapitre IV de l’A.R. du 21 décembre 2001 mentionné dans le tableau ci-dessous en regard de la spécialité concernée&nbsp;:</P><DIV align=center><TABLE class=MsoNormalTable style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 253.05pt; BORDER-COLLAPSE: collapse; BORDER-TOP: medium none; BORDER-RIGHT: medium none; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-alt: solid windowtext .5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext" cellSpacing=0 cellPadding=0 width=337 border=1>    <TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">paragraphe</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD></TR>  <TR style="mso-yfti-irow: 1">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD></TR>  <TR style="mso-yfti-irow: 2">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">2430000</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">COZAAR</P>      <P Class="Text">COZAAR (Impexeco)</P>      <P Class="Text">COZAAR       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 3">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">COZAAR       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 4">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">COZAAR       PLUS FORTE</P>      <P Class="Text">COZAAR       PLUS FORTE (PI-Pharma)       </P></TD></TR>  <TR style="mso-yfti-irow: 5">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD></TR>  <TR style="mso-yfti-irow: 6">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">3580000</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">LYRICA</P>      <P Class="Text">LYRICA       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 7">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text"><A                                                                                     href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00215622**qs_SpcNam=APROVEL**qs_Chp=IV**qs_Prg=3620000"      >3620000</A></P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">APROVEL</P>      <P Class="Text">APROVEL       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 8">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">ATACAND</P></TD></TR>  <TR style="mso-yfti-irow: 9">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">ATACAND       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 10">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">ATACAND       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 11">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">BELSAR</P></TD></TR>  <TR style="mso-yfti-irow: 12">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">BELSAR       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 13">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">CO-DIOVANE</P>      <P Class="Text">CO-DIOVANE       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 14">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">COAPROVEL</P></TD></TR>  <TR style="mso-yfti-irow: 15">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">DIOVANE</P>      <P Class="Text">DIOVANE       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 16">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">EXFORGE</P></TD></TR>  <TR style="mso-yfti-irow: 17">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">EXFORGE       HCT</P></TD></TR>  <TR style="mso-yfti-irow: 18">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">FORZATEN</P>      <P Class="Text">FORZATEN/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 19">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">KINZALKOMB</P></TD></TR>  <TR style="mso-yfti-irow: 20">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">KINZALMONO</P></TD></TR>  <TR style="mso-yfti-irow: 21">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">MICARDIS</P></TD></TR>  <TR style="mso-yfti-irow: 22">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">MICARDISPLUS</P>      <P Class="Text">MICARDISPLUS       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 23">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">OLMETEC</P></TD></TR>  <TR style="mso-yfti-irow: 24">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">OLMETEC       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 25">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">SEVIKAR</P>      <P Class="Text">SEVIKAR/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 26">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">TEVETEN</P></TD></TR>  <TR style="mso-yfti-irow: 27; mso-yfti-lastrow: yes">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.4pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 126.65pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=169>      <P Class="Text">TEVETEN       PLUS</P>      <P Class="Text">TWYNSTA       </P></TD></TR></TABLE></DIV><P Class="Text"></P><P Class="Text">b) Le remboursement est accordé pour autant que le médecin prescripteur, constatant que toutes les conditions du paragraphe concerné au point a) sont remplies pour la spécialité prescrite, y compris les éventuelles conditions relatives à une posologie maximale remboursable et les conditions requises pour d’éventuels renouvellements, et qu’il s’agit d’un patient étant repris dans une convention diabète au moment de la prescription, mentionne sur l’ordonnance «CD» ou «convention diabète». Dans ces conditions, le pharmacien est habilité à appliquer le tiers payant dans le cadre du groupe de remboursement B-310.</P><P Class="Text"></P><P Class="Text">c) Le médecin prescripteur doit tenir à la disposition du médecin-conseil les éléments de preuve établissant que le patient se trouve dans la situation susvisée, y compris, le cas échéant, lorsque les dispositions du paragraphe visé au point a) prévoient que la demande doit être rédigée par un médecin titulaire d’une qualification médicale particulière, une attestation d’un médecin possédant cette qualification qui confirme que les conditions médicales de ce paragraphe sont bien remplies chez le patient concerné.</P><P Class="Text"></P><P Class="Text"></P></TD></TR>
 </TABLE>

<HR>
<H3 ALign="right"><A Name="#3620000"></A>R&eacute;glementation sur le remboursement selon la cat&eacute;gorie B</H3>
  <H3 ALign="right">Contr&ocirc;le a priori (chapitre IV § 3620000)</H3>

<H4>
 <A HREF="..\Attestn/3620000_FormDem_NS_FR.pdf" Target="_blank">Formulaire de demande "non-spécifique" (non obligatoire) </A><BR>
</H4>
 <P>
 <TABLE Width="95%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD Width="5%">&nbsp;</TD>
   <TD vAlign="top"><P Class="Text">La spécialité est remboursée si elle est utilisée pour le traitement de sujets atteints d’hypertension artérielle qui n’ont pas été favorablement influencés par les thérapeutiques classiques ou ont, dans ces conditions, présenté des effets secondaires inacceptables.</P><P Class="Text">Dans ces cas, l’autorisation du médecin-conseil est subordonnée à la réception d’un rapport écrit, comportant l’anamnèse du cas et toutes les précisions nécessaires au sujet des traitements précédents en mentionnant leur nature, les effets secondaires éventuellement constatés ainsi que l’explication des raisons qui ont motivé le recours à un antagoniste des récepteurs de l’angiotensine II.</P><P Class="Text">Sur base de ces éléments, le médecin-conseil délivre au bénéficiaire l’autorisation dont le modèle est fixé sous “d” de l’annexe III de l’arrêté royal du 21.12.2001 et dont la durée de validité est limitée à 12 mois maximum.</P><P Class="Text">Le remboursement de la poursuite du traitement peut-être accordé pour de nouvelles périodes de 60 mois maximum sur base du modèle “d” dûment&nbsp; complété par le médecin traitant et renvoyé au médecin-conseil de l’organisme assureur.<BR></P></TD></TR>
 </TABLE>

<HR>
<H3 ALign="right"><A Name="#5500000"></A>R&eacute;glementation sur le remboursement selon la cat&eacute;gorie B</H3>
  <H3 ALign="right">Contr&ocirc;le a priori (chapitre IV § 5500000)</H3>

 <P>
 <TABLE Width="95%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD Width="5%">&nbsp;</TD>
   <TD vAlign="top"><P Class="Text">a) La spécialité fait l’objet d’un remboursement en catégorie B dans le cadre du groupe de remboursement B-309 si elle est utilisée pour le traitement de patients bénéficiant d’un trajet de soins pour le diabète conformément aux dispositions de l’arrêté royal du 21 janvier 2009 concernant les trajets de soins, pour autant que le patient concerné remplisse toutes les conditions médicales nécessaires pour obtenir le remboursement de la spécialité concernée telles que ces conditions figurent au paragraphe du chapitre IV de l’A.R. du 21 décembre 2001 mentionné dans le tableau ci-dessous en regard de la spécialité concernée&nbsp;:</P><DIV align=center><TABLE class=MsoNormalTable style="WIDTH: 255.2pt; BORDER-COLLAPSE: collapse; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt" cellSpacing=0 cellPadding=0 width=340 border=0>    <TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">paragraphe</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD></TR>  <TR style="mso-yfti-irow: 1">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD></TR>  <TR style="mso-yfti-irow: 2">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">2430000</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">COZAAR</P>      <P Class="Text">COZAAR       (Impexeco)</P>      <P Class="Text">COZAAR       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 3">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">COZAAR       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 4">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">COZAAR       PLUS FORTE</P>      <P Class="Text">COZAAR       PLUS FORTE (PI-Pharma)       </P></TD></TR>  <TR style="mso-yfti-irow: 5">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD></TR>  <TR style="mso-yfti-irow: 6">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">3580000</P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">LYRICA</P>      <P Class="Text">LYRICA       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 7">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text"><A                                                                                     href="http://www.riziv.fgov.be/inami_prd/ssp/cns2/pages/PreviousPageSet.asp?qs_PrvPagRtr=add&amp;qs_Redir=RefundingCondition.asp*qs_SpcCod=00215622**qs_SpcNam=APROVEL**qs_Chp=IV**qs_Prg=3620000"      >3620000</A></P></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">APROVEL</P>      <P Class="Text">APROVEL       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 8">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">ATACAND</P></TD></TR>  <TR style="mso-yfti-irow: 9">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">ATACAND       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 10">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">ATACAND       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 11">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">BELSAR</P></TD></TR>  <TR style="mso-yfti-irow: 12">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">BELSAR       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 13">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">CO-DIOVANE</P>      <P Class="Text">CO-DIOVANE       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 14">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">COAPROVEL</P></TD></TR>  <TR style="mso-yfti-irow: 15">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">DIOVANE</P>      <P Class="Text">DIOVANE       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 16">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">EXFORGE</P></TD></TR>  <TR style="mso-yfti-irow: 17">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">EXFORGE       HCT</P></TD></TR>  <TR style="mso-yfti-irow: 18">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">FORZATEN</P>      <P Class="Text">FORZATEN/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 19">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">KINZALKOMB</P></TD></TR>  <TR style="mso-yfti-irow: 20">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">KINZALMONO</P></TD></TR>  <TR style="mso-yfti-irow: 21">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">MICARDIS</P></TD></TR>  <TR style="mso-yfti-irow: 22">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">MICARDISPLUS</P>      <P Class="Text">MICARDISPLUS       (PI-Pharma)</P></TD></TR>  <TR style="mso-yfti-irow: 23">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">OLMETEC</P></TD></TR>  <TR style="mso-yfti-irow: 24">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">OLMETEC       PLUS</P></TD></TR>  <TR style="mso-yfti-irow: 25">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">SEVIKAR</P>      <P Class="Text">SEVIKAR/HCT</P></TD></TR>  <TR style="mso-yfti-irow: 26">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">TEVETEN</P></TD></TR>  <TR style="mso-yfti-irow: 27; mso-yfti-lastrow: yes">    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170></TD>    <TD                                                                                                                                                                                                                style="BORDER-BOTTOM: #e0dfe3; BORDER-LEFT: #e0dfe3; PADDING-BOTTOM: 0cm; BACKGROUND-COLOR: transparent; PADDING-LEFT: 5.4pt; WIDTH: 127.6pt; PADDING-RIGHT: 5.4pt; BORDER-TOP: #e0dfe3; BORDER-RIGHT: #e0dfe3; PADDING-TOP: 0cm"     vAlign=top width=170>      <P Class="Text">TEVETEN       PLUS</P>      <P Class="Text">TWYNSTA       </P></TD></TR></TABLE></DIV><DIV align=center>&nbsp;</DIV><P Class="Text"></P><P Class="Text">b) Le remboursement est accordé pour autant que le médecin prescripteur, constatant que toutes les conditions du paragraphe concerné au point a) sont remplies pour la spécialité prescrite, y compris les éventuelles conditions relatives à une posologie maximale remboursable et les conditions requises pour d’éventuels renouvellements, et qu’il s’agit d’un patient bénéficiant d’un trajet de soins pour le diabète au moment de la prescription, mentionne sur l’ordonnance «TSD» ou «trajet de soins diabète». Dans ces conditions, le pharmacien est habilité à appliquer le tiers payant dans le cadre du groupe de remboursement B-309.</P><P Class="Text"></P><P Class="Text">c) Le médecin prescripteur doit tenir à la disposition du médecin-conseil les éléments de preuve établissant que le patient se trouve dans la situation susvisée, y compris, le cas échéant, lorsque les dispositions du paragraphe visé au point a) prévoient que la demande doit être rédigée par un médecin titulaire d’une qualification médicale particulière, une attestation d’un médecin possédant cette qualification qui confirme que les conditions médicales de ce paragraphe sont bien remplies chez le patient concerné.</P><P Class="Text"></P><P Class="Text"></P></TD></TR>
 </TABLE>

<script language="JavaScript">
function GT_openWindow(deURL) {
window.open(deURL,'Riziv','width=650,height=120,scrollbars=1');
}
</script>

</BODY>
</HTML>
